|
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical research trials and A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer. A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer clinical trial. Test subjects typically obtain the finest healthcare available for their A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer  A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
For Condition: Non-small cell lung cancer
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: The purpose of the study is to determine if ABT-751 will decrease tumors, and determine how long the tumor shrinkage can be maintained in patients with non-small cell lung cancer. Patients will receive ABT-751 by mouth daily for 21 days. Patients will be off drug for 7 days before starting the next cycle of drug.
Details:
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Stage IIIB or IV non-small cell lung cancer. - Recurrent tumor following treatment with paclitaxel or docetaxel. - Not pregnant or breast feeding. - Able to tolerate normal activites of daily living. - No anti-tumor therapy within 4 weeks of the start of ABT-751 administration. - No CNS metastasis. - Adequate bone marrow, kidney and liver function.
Total Enrollment:
Location and Contact Information:
Cancer Care Northwest *Recruiting*
Spokane, Washington,
United States
Recruiting Rosalee Miller 509-464-5100
West Cancer Clinic *Recruiting*
Memphis, Tennessee, 38120
United States
Recruiting Marnie Brotherton 901-683-0055
Florida Cancer Institute *Recruiting*
New Port Richey, Florida,
United States
Recruiting Greta Nobles 727-842-8411
Cancer Centers of the Carolinas *Recruiting*
Greenville, South Carolina,
United States
Recruiting Janis Barrieau 864-987-7000
University of Maryland Greenbaum Cancer Center *Recruiting*
Baltimore, Maryland, 21201-1595
United States
Recruiting Ruth Smith 410-328-9166
University of Chicago Medical Center *Recruiting*
Chicago, Illinois, 60637-1460
United States
Recruiting Livia Szeto 773-834-0783
University of Wisconsin Comprehensive Cancer Center *Recruiting*
Madison, Wisconsin, 53792-5666
United States
Recruiting Lana Hammes 608-262-8126
Albany Regional Cancer Center *Recruiting*
Albany, New York,
United States
Recruiting James Arsneau 518-489-2607
Texas Oncology *Recruiting*
Ft. Worth, Texas,
United States
Recruiting Robert Ruxer 817-338-4333
Oncology & Hematology Associates of Kansas City, PA *Recruiting*
Kansas City, Missouri, 64111
United States
Recruiting Vickie Thomas 913-514-4641
Raleigh Hematology Oncology *Recruiting*
Cary, North Carolina,
United States
Recruiting Diane Bracco 919-852-1994
Oncology Hematology Group of South Florida *Recruiting*
Miami, Florida,
United States
Recruiting Kathy Maxwell 901-683-0055
Cancer Care Associates *Recruiting*
Oklahoma City, Oklahoma,
United States
Recruiting Nancy Cleaner 405-751-4343
Northwest Cancer Specialists *Recruiting*
Vancouver, Washington,
United States
Recruiting Judith Welch 360-944-9889
Washington University School of Medicine *Recruiting*
St. Louis, Missouri, 63110-1093
United States
Recruiting Linda Dunn 314-747-1849
Texas Oncology *Recruiting*
Dallas, Texas,
United States
Recruiting Kristi McIntyre 214-739-4175
Texas Oncology *Recruiting*
Dallas, Texas,
United States
Recruiting Joanne Blum 214-370-1000
Dayton Oncology and Hematology *Recruiting*
Kettering, Ohio,
United States
Recruiting Michele Owens 937-293-1622
Additional Information:
Study ID Numbers: M02-448;
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00073151
Other Non-Small Cell Lung Cancer Studies:
1. GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors
2. Oltipraz in the Prevention of Lung Cancer in People Who Smoke
3. Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
4. Comparison of Two Combination Chemotherapy Regimens in Treating Non-small Cell Lung Cancer
5. Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Related Studies:
Other Non-small cell lung cancer Clinical Trials
Other Wisconsin Clinical Trials
Other Madison Clinical Trials
A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
|
|
|
|
|
|
|
|
